Highlights of The Neurotechnology Industry 2007 Report
The three sectors of the neurotechnology industry are revealed with new 2007 revenue breakdowns for neuropharmaceuticals, neurodevices and neurodiagnostics
Up-to-date market data and detailed competitive intelligence for over 15 major markets including Alzheimer’s, addiction, anxiety, depression, epilepsy, mild cognitive impairment, obesity, pain, Parkinson’s, schizophrenia, sensory disorders, sleep disorders, stroke and more
Compounds and devices in clinical trials by company, mechanism of action, and stage of development
Profiles of 500 public & private neurotech including neuropharmaceutical, neurodevice, neurodiagnostic companies (see list)
Worldwide government research, private funding and public investment trends
Analysis of the 10 most active neurotech venture capital firms, including investments by market segment
Public neurotech investment trends, including a neurotech tracking index highlighting 30 public neurotech companies
Extensive discussion of the specific technological, demographic, regulatory, and IP trends driving neurotech